Summary & Overview
CPT 53453: Removal of Periurethral Balloon Continence Device
CPT code 53453 represents the surgical removal of a balloon continence device that was previously placed adjacent to the urethra using a minimally invasive transperineal technique. This code captures a targeted, device-related procedure for patients with implantable periurethral balloon systems and is relevant to urology, female pelvic medicine, and surgical device management. Nationally, accurate use of this code matters for procedure tracking, device-related outcomes reporting, and appropriate claims processing.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise view of the clinical context for 53453, typical sites of service, and the set of commonly reported modifiers associated with the service. The content addresses billing and coding contours, utilization benchmarks where available, and relevant policy considerations affecting coverage and claim adjudication. Data not available in the input is noted where applicable.
The publication equips billing managers, coding professionals, and policy analysts with the essential clinical description, payer landscape, and topics to evaluate further when managing claims for removal of periurethral balloon continence devices.
Billing Code Overview
CPT code 53453 describes removal of a balloon continence device placed adjacent to the urethra via a minimally invasive transperineal approach. The service involves surgical extraction of a previously implanted periurethral balloon continence device.
-
Service type: Surgical removal of implantable continence device
-
Typical site of service: Ambulatory surgery center or hospital outpatient surgical department
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult (commonly male) with a previously placed transperineal periurethral balloon continence device presenting for elective removal due to device malfunction, pain, infection, erosion, urinary retention, or patient preference. The patient often arrives to an ambulatory surgery center or hospital outpatient department after preoperative evaluation confirming indication for removal and reviewing prior operative reports documenting transperineal placement. Under monitored anesthesia care or general anesthesia, the urologist or female pelvic medicine specialist exposes the perineal/transperineal access site, identifies the balloon device and its components, and removes the device and any associated reservoir or catheter. The specimen is inspected and sent for culture or pathology if infection or erosion is suspected. Postoperative care includes short-term observation for urinary retention, hematuria, or wound issues, discharge with wound care and activity restrictions, and follow-up to assess continence status and plan for alternative therapy if needed.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier — standard reporting | Use when no additional reporting modifier is required and service is billed routinely. |
22 |